64. HS-104, a PI3K inhibitor, enhances anticancer efficacy of gemcitabine in pancreatic cancer
Jung, K. H.; Yan, H. H.; Fang, Z.; Son, M. K.; Lee, H.; Hong, S.; Hong, S.-S.
Int. J. Oncol. 2014, 45, 311-321.
63. AgSbF6-Controlled Diastereodivergence in Alkyne Hydroarylation: Facile Access to Z- and E-Alkenyl Arenes
Min, M.; Kim, D.; Hong, S.
Chem. Commun. 2014, 50, 8028.
62. Biophysical characterization of sites of host adaptive mutation in the influenza A virus RNA polymerase PB2 RNA-binding domain
Lim, K.; Kim, M.; Lee, M.-K.; Ko, J.; Hong, S.; Choi, B.-S.
Int. J. Biochem. Cell Biol. 2014, 53, 237.
61. Development and Biological Evaluation of Potent and Selective c-KITD816V Inhibitors
Lee, S.; Lee, H.; Kim, J.; Lee, S.; Kim, S. J. ; Hong, S.-S.; Hong, S.
J. Med. Chem. 2014, 57, 6428.
60. HS-438, a New Inhibitor of Imatinib-Resistant BCR-ABL T315I Mutation in Chronic Myeloid Leukemia
Yun, S.-M., Jung, K. H.; Kim S. J.; Fang, Z. H.; Son, M. K.; Yan, H. H.; Lee, H.; Kim, J.; Shin, S.; Hong, S.*; Hong, S.-S.*
Cancer Lett. 2014, 348, 50.
59. Synthesis of Heterocyclic-Fused Benzopyrans via the Pd(II)-Catalyzed C–H Alkenylation/C–O Cyclization of Flavones and Coumarins
Kim, Y.; Moon, Y.; Kang, D.; Hong, S.
Org. Biomol. Chem. 2014, 12, 3413. (Highlighted in Synfact July 2014)
58. Selective and Potent Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinases
Jeong, Y.; Kwon, D.; Hong, S.
Future Med. Chem. 2014, 6, 737.
57. Structure-based de novo design and identification of D816V mutant-selective c-KIT inhibitors
Park, H.; Lee, S.; Lee, S.; Hong, S.
Org. Biomol. Chem. 2014, 12, 4644.
56. One-Pot Dehydrogenative Aromatization and Ortho-Functionalization Sequence of N-Acetyl Enamides
Kim, J.; Moon, Y.; Lee, S. Hong, S.
Chem. Commun. 2014, 50, 3227.
55. Virtual Screening and Biochemical Evaluation to Identify New Inhibitors of Mammalian Target of Rapamycin (mTOR)
Park, H.; Choe, H.; Hong, S.
Bioorg. Med. Chem. Lett. 2014, 24, 835.
